| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5645282 | Annals of Allergy, Asthma & Immunology | 2016 | 4 Pages |
Abstract
Our study found that omalizumab is a well-tolerated and effective therapy for elderly patients with uncontrolled asthma.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Tugba Songul MD, Aykut MD,